Form 4: Columbia Financial Officer Acquires Shares, Details Equity Holdings

John Klimowich, SEVP & Chief Risk Officer of Columbia Financial, Inc., reported an acquisition of common stock and detailed his extensive equity and derivative holdings.

Summary

• John Klimowich, SEVP & Chief Risk Officer of Columbia Financial, Inc. (CLBK), reported an acquisition of 41.5935 shares of common stock on August 22, 2025, at a price of $15.35 per share.
• The acquisition represents phantom stock purchased on a non-discretionary basis by the trustee of the Bank's rabbi trust, part of the Columbia Bank Stock Based Deferral Plan.
• Following this transaction, Mr. Klimowich beneficially owns 7,764.9975 shares indirectly through the Stock-Based Deferral Plan.
• Additional indirect holdings include 17,130 shares via 401(k), 7,620 shares via ESOP, 7,051 shares via SERP, 4,214 shares via SIM, 13,781 shares via Stock Award II, 12,068 shares via Stock Award III, and 11,723 shares via Stock Award IV.
• Direct beneficial ownership of common stock totals 60,769 shares.
• Mr. Klimowich also holds various stock options (right to buy) directly, including 188,235 options fully vested at an exercise price of $15.60, expiring July 23, 2029.
• Other stock options include 12,030 options vesting from May 1, 2024, at $15.94 exercise price; 8,850 options vesting from March 6, 2025, at $16.49 exercise price; and 20,310 options vesting from March 3, 2026, at $16.23 exercise price.

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of an insider transaction. The acquisition, while small and non-discretionary, generally reflects a neutral to slightly positive signal of management's aligned interests with the company's performance.

Positives

• An officer's acquisition of shares, even if non-discretionary, generally signals alignment of management's interests with shareholders.
• The extensive holdings of common stock, stock awards, and stock options demonstrate a significant equity stake by a key executive, fostering long-term commitment.
• The existence of multiple equity incentive plans (Stock-Based Deferral Plan, 2019 Equity Incentive Plan) indicates a structured approach to executive compensation and retention.

Future Outlook

Future vesting schedules for various stock awards and options extend through March 2028 for stock awards and March 2035 for stock options, indicating long-term incentive structures for the reporting person.

Management Comments

• No direct quotes or paraphrased statements from company management are provided in this Form 4 filing, which is a transactional disclosure document.

Industry Context

Form 4 filings are standard regulatory disclosures for insider transactions in publicly traded companies. The structure of equity compensation, including stock options and performance-based awards, is common practice in the financial services industry to align executive incentives with shareholder value creation.

Comparison to Industry Standards

• The disclosure of executive equity holdings and transactions via Form 4 is a standard regulatory requirement, aligning with transparency benchmarks across the industry.
• The use of a 2019 Equity Incentive Plan with a mix of time-based and performance-based vesting for stock awards and options is a common compensation strategy seen in comparable financial institutions, designed to incentivize long-term performance and retention.

Corporate Governance

Related Party Transactions

• The reported acquisition of phantom stock units by John Klimowich, an executive officer, constitutes an insider transaction, which is a form of related party dealing within the company's compensation structure.

Stakeholder Impact

• Shareholders benefit from the transparency of insider holdings and transactions, which can provide insights into management's confidence in the company's future.
• Employees, particularly those participating in similar equity plans, may see this as a reaffirmation of the company's commitment to performance-based compensation.

Next Steps

• Vesting of Stock Options (exercise price $15.94) will continue in approximately equal annual installments from May 1, 2024.
• Vesting of Stock Options (exercise price $16.49) will commence in approximately equal annual installments from March 6, 2025.
• Vesting of Stock Options (exercise price $16.23) will commence in approximately equal annual installments from March 3, 2026.
• Stock Award II will continue to vest, with 25% in three approximately equal annual installments commencing May 1, 2024, and the remaining 75% upon achievement of performance criteria.
• Stock Award III will continue to vest, with 25% in three approximately equal annual installments commencing March 6, 2025, and the remaining 75% upon achievement of performance criteria.
• Stock Award IV is scheduled to vest upon achievement of performance-based criteria on March 3, 2028.

Key Dates

Recommendation

This Form 4 filing primarily details an officer's equity holdings and a small, non-discretionary acquisition of phantom stock units. While an insider purchase can signal confidence, the transaction size and nature (phantom stock via deferral plan) are not significant enough to warrant a change in investment thesis. The extensive equity and option holdings align management's interests with shareholders, supporting a 'hold' recommendation based solely on this disclosure.

Keywords

Columbia Financial, CLBK, Form 4, Insider Transaction, Stock Acquisition, Equity Incentive Plan, Stock Options, Executive Compensation, John Klimowich, Beneficial Ownership